Skip to content
Clinical Trials – home
Johnson & Johnson Enterprise Innovation Inc.
Sponsor

Johnson & Johnson Enterprise Innovation Inc.

United States 1 Johnson And Johnson Plaza, 08933-0001, United States

About the sponsor

Clinical research includes advanced non-small cell lung cancer and locally advanced unresectable stage III NSCLC, with interest in combining radiotherapy with systemic and local treatment approaches.

  • Radioenhancing cancer therapy
  • Chemoradiation
  • Immune checkpoint inhibition
  • Durvalumab

The portfolio reflects a focus on treatment strategies for lung tumors that are difficult to control with standard local therapy alone.

About Specializations

Johnson & Johnson Enterprise Innovation Inc. runs clinical trials in conditions such as Head and neck cancer, Non-small cell lung cancer, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Cetuximab
  • Sponsor:Johnson & Johnson Enterprise Innovation Inc.
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:HAFNIUM OXIDE
  • Sponsor:Johnson & Johnson Enterprise Innovation Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.